Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders Jessica Taft El vértigo horizontal

El vértigo horizontal

cl/blogs/autores-webook/francisco-arce

sus bellas concepciones sobre la formación y jerarquización de los mundos

de Gonzalo de Berceo

Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders Jessica Taft El vértigo horizontalExamining Glucagon Like Peptide 1 Receptor (GLP 1R) Agonists for Central Nervous System Disorders Glucagon like peptide 1 receptor (GLP 1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurposing GLP 1R agonists to treat some central nervous disorders is promising, but comparatively understudied.